These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22783166)

  • 1. Cystatin C in Alzheimer's disease.
    Kaur G; Levy E
    Front Mol Neurosci; 2012; 5():79. PubMed ID: 22783166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis.
    Zhong XM; Hou L; Luo XN; Shi HS; Hu GY; He HB; Chen XR; Zheng D; Zhang YF; Tan Y; Liu XJ; Mu N; Chen JP; Ning YP
    PLoS One; 2013; 8(1):e55328. PubMed ID: 23383156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C protects neuronal cells from amyloid-beta-induced toxicity.
    Tizon B; Ribe EM; Mi W; Troy CM; Levy E
    J Alzheimers Dis; 2010; 19(3):885-94. PubMed ID: 20157244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of amyloid-beta and cystatin C in the human central nervous system.
    Mi W; Jung SS; Yu H; Schmidt SD; Nixon RA; Mathews PM; Tagliavini F; Levy E
    J Alzheimers Dis; 2009; 18(2):273-80. PubMed ID: 19584436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.
    Maetzler W; Schmid B; Synofzik M; Schulte C; Riester K; Huber H; Brockmann K; Gasser T; Berg D; Melms A
    J Alzheimers Dis; 2010; 19(3):937-42. PubMed ID: 20157249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.
    Castaño EM; Prelli F; Soto C; Beavis R; Matsubara E; Shoji M; Frangione B
    J Biol Chem; 1996 Dec; 271(50):32185-91. PubMed ID: 8943274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C in aging and in Alzheimer's disease.
    Mathews PM; Levy E
    Ageing Res Rev; 2016 Dec; 32():38-50. PubMed ID: 27333827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Abeta40 deposition was associated with increased Abeta42-43 in cerebral vasculature with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D).
    Ozawa K; Tomiyama T; Maat-Schieman ML; Roos RA; Mori H
    Ann N Y Acad Sci; 2002 Nov; 977():149-54. PubMed ID: 12480745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.
    Sun B; Zhou Y; Halabisky B; Lo I; Cho SH; Mueller-Steiner S; Devidze N; Wang X; Grubb A; Gan L
    Neuron; 2008 Oct; 60(2):247-57. PubMed ID: 18957217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
    Hansson SF; Andréasson U; Wall M; Skoog I; Andreasen N; Wallin A; Zetterberg H; Blennow K
    J Alzheimers Dis; 2009; 16(2):389-97. PubMed ID: 19221428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.
    Perlenfein TJ; Murphy RM
    J Biol Chem; 2017 Dec; 292(51):21071-21082. PubMed ID: 29046353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant.
    Levy E; Prelli F; Frangione B
    J Alzheimers Dis; 2006; 9(3 Suppl):329-39. PubMed ID: 16914871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.